Delcath Systems, Inc.
DCTHNASDAQHealthcare● Active
$10.94
+$0.27(+2.53%)
Market Cap$377666818
P/E Ratio—
52W High$17.352
52W Low$8.12
Delcath Systems, Inc. (DCTH) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DCTH · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.03
Est. -$0.09 · +68.1%
Revenue
$0.03B
Est. $0.02B · +6.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 4-Quarter EPS Beat Streak
DCTH reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | -$0.09 | — | — | — | $0.03B | — |
| ▲ Q2 FY2026 | May 7, 2026 | -$0.09 | -$0.03 | +68.1% | $0.03B | $0.02B | +6.3% |
| ▲ Q1 FY2026 | Feb 26, 2026 | -$0.06 | -$0.05 | +20.6% | $0.02B | $0.02B | +0.7% |
| — Q4 FY2025 | Nov 4, 2025 | $0.02 | $0.02 | +0.0% | $0.02B | $0.02B | +1.0% |
| ▲ Q3 FY2025 | Aug 6, 2025 | $0.03 | $0.07 | +169.2% | $0.02B | $0.02B | +4.9% |
| ▼ Q2 FY2025 | May 8, 2025 | $0.10 | $0.03 | -70.0% | $0.02B | $0.02B | +6.1% |
| ▲ Q1 FY2025 | Mar 6, 2025 | -$0.10 | $0.05 | +150.0% | $0.02B | $0.02B | -9.4% |
| ▲ Q4 FY2024 | Nov 8, 2024 | -$0.13 | -$0.03 | +76.9% | $0.01B | $0.01B | -23.0% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
-$0.09
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
-$0.03
EPS Est.
-$0.09
EPS Surpr.
+68.1%
Revenue
$0.03B
Q1 FY2026
Feb 26, 2026Beat
EPS Actual
-$0.05
EPS Est.
-$0.06
EPS Surpr.
+20.6%
Revenue
$0.02B
Q4 FY2025
Nov 4, 2025
EPS Actual
$0.02
EPS Est.
$0.02
EPS Surpr.
+0.0%
Revenue
$0.02B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
$0.07
EPS Est.
$0.03
EPS Surpr.
+169.2%
Revenue
$0.02B
Q2 FY2025
May 8, 2025Miss
EPS Actual
$0.03
EPS Est.
$0.10
EPS Surpr.
-70.0%
Revenue
$0.02B
Q1 FY2025
Mar 6, 2025Beat
EPS Actual
$0.05
EPS Est.
-$0.10
EPS Surpr.
+150.0%
Revenue
$0.02B
Q4 FY2024
Nov 8, 2024Beat
EPS Actual
-$0.03
EPS Est.
-$0.13
EPS Surpr.
+76.9%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q3 FY2028 | $-0.06 | $-0.06 | $-0.05 | 1 |
| Q2 FY2028 | $-0.02 | $-0.02 | $-0.02 | 1 |
| Q1 FY2028 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q4 FY2027 | $-0.20 | $-0.19 | $-0.18 | 1 |
| Q3 FY2027 | $-0.23 | $-0.21 | $-0.20 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +68.1% | $11.26 | $11.24 | -0.18% |
| ▲ Q1 FY2026 | Feb 26, 2026 | +20.6% | $10.21 | $9.00 | -11.85% |
| ▲ Q4 FY2025 | Nov 4, 2025 | +0.0% | $9.52 | $9.08 | -4.62% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +169.2% | $10.52 | $10.64 | +1.14% |
| ▼ Q2 FY2025 | May 8, 2025 | -70.0% | $11.61 | $14.36 | +23.69% |
| ▲ Q1 FY2025 | Mar 6, 2025 | +150.0% | $13.43 | $13.22 | -1.56% |
| ▲ Q4 FY2024 | Nov 8, 2024 | +76.9% | $10.94 | $11.06 | +1.10% |
| ▼ Q3 FY2024 | Aug 5, 2024 | -41.2% | $8.12 | $8.32 | +2.46% |
Q2 FY2026-0.18%
Report Date
May 7, 2026
EPS Beat/Miss
+68.1%
Price Before
$11.26
Price After
$11.24
Q1 FY2026-11.85%
Report Date
Feb 26, 2026
EPS Beat/Miss
+20.6%
Price Before
$10.21
Price After
$9.00
Q4 FY2025-4.62%
Report Date
Nov 4, 2025
EPS Beat/Miss
+0.0%
Price Before
$9.52
Price After
$9.08
Q3 FY2025+1.14%
Report Date
Aug 6, 2025
EPS Beat/Miss
+169.2%
Price Before
$10.52
Price After
$10.64
Q2 FY2025+23.69%
Report Date
May 8, 2025
EPS Beat/Miss
-70.0%
Price Before
$11.61
Price After
$14.36
Q1 FY2025-1.56%
Report Date
Mar 6, 2025
EPS Beat/Miss
+150.0%
Price Before
$13.43
Price After
$13.22
Q4 FY2024+1.10%
Report Date
Nov 8, 2024
EPS Beat/Miss
+76.9%
Price Before
$10.94
Price After
$11.06
Q3 FY2024+2.46%
Report Date
Aug 5, 2024
EPS Beat/Miss
-41.2%
Price Before
$8.12
Price After
$8.32
Avg Beat Reaction-2.66%
Avg Miss Reaction+13.08%
Beat Rate6 / 8 quarters
Largest Move+23.69% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DCTH ends December
Delcath Systems, Inc. (DCTH) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.03 — beating the analyst consensus of $-0.09 by +68.1%. DCTH has beaten EPS estimates for 4 consecutive quarters. The next DCTH earnings date is expected around September 1, 2026.
Each quarter, investors track DCTH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DCTH revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DCTH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DCTH earnings · 5 questionsDelcath Systems, Inc.'s next earnings report is expected around September 1, 2026. DCTH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DCTH historically reports after market close (AMC).
DCTH earnings datewhen is DCTH earningsDCTH next earnings datewhen does DCTH report earningsDCTH earnings calendar
▸ Source: FMP · Delcath Systems, Inc. SEC filings · US GAAP · Delcath Systems, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026